November 29, 2006
KALYPSYS RAISES $100 MILLION IN A SERIES C FINANCING

November 6, 2006
INDIANA UNIVERSITY AND MARCADIA BIOTECH COLLABORATE TO DEVELOP PROMISING TREATMENTS FOR METABOLIC DISEASES

November 4, 2006
EX-LILLY EXECS TAKE ON DIABETES: CARMEL STARTUP MARCADIA LED BY BIOTECH BIG GUNS WATANABE, DIMARCHI

November 1, 2006
ENTREMED COMMENCES PHASE 2 CLINICAL TRIAL WITH PANZEM NCD IN OVARIAN CANCER

October 25, 2006
ACHAOGEN AWARDED $24.7M BIODEFENSE CONTRACT BY DTRA

October 12, 2006
KALOBIOS APPOINTS DAVID W. PRITCHARD AS PRESIDENT AND CEO

October 10, 2006
ACHAOGEN CLOSES SERIES B FINANCING

September 26, 2006
KALYPSYS ON TRACK TO COMPLETE PHASE IA STUDY FOR DRUG CANDIDATE, KD3010, FOR METABOLIC DISORDERS BY END OF OCTOBER

September 12, 2006
ENTREMED COMMENCES PANZEM NCD PHASE 2 STUDY IN PROSTATE CANCER

July 5, 2006
AMBRX SECURES $52 MILLION IN SERIES C FINANCING

May 31, 2006
KALOBIOS COLLABORATES TO ENGINEER HUMAN ANTIBODY THERAPEUTIC DRUGS

May 25, 2006
ANTIPODEAN PHARMACEUTICALS INITIATES PHASE II TRIAL IN PARKINSON'S DISEASE

May 15, 2006
ENTREMED INITIATES COMBINATION PHASE 2 CLINICAL TRIAL WITH PANZEM NCD IN CARCINOID CANCER

April 27, 2006
ILYPSA AND ASTELLAS PHARMA INC. ENTER INTO A LICENSE AGREEMENT THAT GIVES ASTELLAS EXCLUSIVE RIGHTS TO DEVELOP AND MARKET ILY101 IN JAPAN

April 25, 2006
PANOMICS ANNOUNCES FORMATION OF NEW EUROPEAN SUBSIDIARY

April 11, 2006
ANTIPODEAN PHARMACEUTICALS ESTABLISHES SAN FRANCISCO HEADQUARTERS

March 8, 2006
ALEXZA PHARMACEUTICALS, INC. SETS PRICE FOR INITIAL PUBLIC OFFERING

February 10, 2006
GENOSPECTRA ANNOUNCES THE ACQUISITION OF PANOMICS, A LEADING REAGENTS PROVIDER

February 10, 2006
SIGMA-ALDRICH STRENGTHENS POSITION IN RNAi AND CELL-BASED ASSAYS THROUGH LICENSING AND EQUITY POSITION IN GENOSPECTRA

February 3, 2006
ENTREMED RAISES $30 MILLION IN PRIVATE PLACEMENT

January 31, 2006
ISIS PHARMACEUTICALS LICESNSES PROPRIETARY ANTIBIOTIC PROGRAM TO ACHAOGEN

January 11, 2006
ENTREMED COMPLETES ACQUISITION OF MIIKANA THERAPEUTICS

January 5, 2006
ILYPSA ANNOUNCES APPOINTMENT OF JAY P. SHEPPARD AS PRESIDENT AND CEO

January 4, 2006
KALYPSYS ANNOUNCES SMALL MOLECULE RESEARCH COLLABORATION WITH ALCON

January 2, 2006
BIOCENTURY: ENTREMED ACQUIRES MIIKANA THERAPEUTICS